Proto Script Pharmaceutical Corp. booked $789.0k in FY2016 revenue, contracting 10% year over year — slower than 78% of Industrials companies we track, at a -910.4% net margin.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.